Xylistin 0.5MIU Injection
By Xylistin
Rx
10ml Injection in a Vial

Composition
Colistimethate Sodium(500000IU)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
July, 2026

liver
Safety Advice - Liver Limited information is available regarding the use of Xylistin 0.5MIU Injection in individuals with liver disease. It is essential to inform your doctor of any history of liver impairment or disorders before receiving this injection. Your doctor may need to make adjustments to the dosage or recommend a different treatment option that is more suitable for your condition. It is important to follow your doctor's guidance closely to ensure the safe and effective use of Xylistin 0.5MIU Injection. Please consult with your doctor for proper guidance before using Xylistin 0.5MIU Injection.

kidney
Xylistin 0.5MIU Injection requires caution in patients with kidney disease. Dosage adjustment may be necessary. Inform your doctor if you have severe kidney issues, as they may adjust the dose or suggest an alternative.

alcohol
Limit alcohol intake while using Xylistin 0.5MIU Injection to avoid increased drowsiness, dizziness, or sleepiness. No harmful side effects reported with alcohol consumption.

driving
Caution should be taken when driving after using Xylistin 0.5MIU Injection. It may lower alertness, impact vision, cause drowsiness, or dizziness. Avoid driving if experiencing these effects. Side effects like visual disturbances and dizziness may make driving unsafe; wait until feeling better before driving.

pregnancy
Xylistin 0.5MIU Injection may not be safe during pregnancy. Limited human studies and animal research have shown potential harm to the baby. Inform your doctor if pregnant or suspect pregnancy for a careful assessment of benefits and risks before using.

breastfeeding
Xylistin 0.5MIU Injection may be considered safe during breastfeeding based on limited human data showing no significant risk to the baby. However, it is advised not to use Xylistin 0.5MIU Injection 10 ml in nursing mothers unless necessary. Consult your doctor to assess benefits and potential risks before use.
| Habit Forming | No |
| Chemical Class | Polypeptides |
| Therapeutic Class | GASTRO INTESTINAL |
| Action Class | Cell membrane active agent |
₹823.9
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025
